Double-blind, placebo-controlled study of the efficacy of trazodone in alcohol post-withdrawal syndrome: Polysomnographic and clinical evaluations

Journal of Clinical Psychopharmacology

Volumn 23, Issue 4, 2003, Pages 377-383

  Le Bon, Olivier ^a   Murphy, James R ^b   Staner, Luc ^b   Hoffmann, Guy ^a   Kormoss, Nicolas ^b   Kentos, Monique ^a   Dupont, Philippe ^a   Lion, Karin ^a   Pelc, Isidore ^a   Verbanck, Paul ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

^b CHU Brugmann S78 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; HYPNOTIC SEDATIVE AGENT; PLACEBO; THIAMINE; TRAZODONE;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS TOLERANCE; DETOXIFICATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HANGOVER; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RELAPSE; REM SLEEP; SEDATION; SKIN IRRITATION; SLEEP DISORDER; TREATMENT OUTCOME; VERTIGO; WAKEFULNESS;

ADOLESCENT; ADULT; AGED; ALCOHOLISM; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOUBLE-BLIND METHOD; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TRAZODONE;

EID: 0042133410     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000085411.08426.d3     Document Type: Article

References (43)

1. Lester BK, Rundell OH, Cowden LC, et al. Chronic alcoholism, alcohol and sleep. In: Gross MM, ed. Alcohol Intoxication and Withdrawal: Experimental Studies. 1: Advances in Experimental Medicine and Biology. Vol 35. New York: Plenum; 1973:261-280.
2. Snyder S, Karakan I. Sleep patterns of sober chronic alcoholics. Neuropsychobiology. 1985;13:97-100.
3. Gillin JC, Smith TL, Irwin M, et al. EEG sleep studies in "pure" primary alcoholism during subacute withdrawal: relationships to normal controls, age, and other clinical variates. Biol Psychiatry. 1990;27:477-488.
4. Aldrich MS, Shipley JE. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res. 1993;17:192-196.
5. Le Bon O, Verbanck P, Hoffmann G, et al. Sleep in detoxified alcoholics: impairment of most standard sleep parameters and increased risk for sleep apnea - but not for myoclonias - a controlled study. J Stud Alcohol. 1997;58:30-36.
6. Drummond SP, Gillin JC, Smith TL, et al. The sleep of abstinent pure primary alcoholic patients: natural course and relationship to relapse. Alcohol Clin Exp Res. 1998;22(8):1796-1802.
7. Adamson J, Burdick JA. Sleep of dry alcoholics. Arch Gen Psychiatry. 1973;28:146-149.
8. Gross MM, Hastey JM. Sleep disturbances in alcoholism. In: Tarter R, Sugarman A, eds. Alcoholism: Interdisciplinary Approaches to Enduring Problem. Reading, MA: Addison-Wesley; 1976:257-309.
9. Williams HL, Rundell OH. Altered sleep physiology in chronic alcoholics: reversal with abstinence. Alcohol Clin Exp Res. 1981;5:318-325.
10. Brower KJ, Aldrich MS, Hall JM. Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin Exp Res. 1998;22(8): 1864-1871.
11. Roehrs T, Papineau K, Rosenthal L, et al. Ethanol as a hypnotic in insomniacs: self-administration and effects on sleep and mood. Neuropsychopharmacology. 1999;20(3):279-286.
12. Brower KJ, Aldrich MS, Robinson EA, et al. Insomnia, self-medication, and relapse to alcoholism. Am J Psychiatry. 2001;158(3):399-404.
13. Landolt HP, Gillin JC. Sleep abnormalities during abstinence in alcohol-dependent patients and management. CNS Drugs. 2001;15(5):413-425.
14. Meyer RE. Prospects for a rational pharmacotherapy of alcoholism. J Clin Psychiatry. 1989;50:403-412.
15. Hollister LE. Interactions between alcohol and benzodiazepines. Recent Dev Alcohol. 1990;8:233-239.
16. Chan AW, Schanley DL, Aleo MD, et al. Cross-tolerance between ethanol and chlordiazepoxide. Alcohol. 1985;2(2):209-213.
17. Chan AW, Langan MC, Leong FW, et al. Does chronic ethanol intake confer full cross-tolerance to chlordiazepoxide? Pharmacol Biochem Behav. 1988;30(2):385-389.
18. Harris RA. Distinct actions of alcohols, barbiturates and benzodiazepines on GABA-activated chloride channels. Alcohol. 1990;7(3): 273-275.
19. Toki S, Saito T, Nabeshima A, et al. Changes in GABAA receptor function and cross-tolerance to ethanol in diazepam-dependent rats. Alcohol Clin Exp Res. 1996;20(suppl 1):40A-44A.
20. Mattila MJ, Vanakoski J, Kalska H, et al. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav. 1998;59(4):917-923.
21. Karam-Hage M, Brower KJ. Gabapentin treatment for insomnia associated with alcohol dependence. Am J Psychiatry. 2000;157(1): 151.
22. Silvestrini B., Valeri P. Trazodone, a new avenue in the treatment of depression. Psychopathology. 1984;17(suppl 2):3-14.
23. Saletu-Zyhlarz GM, Abu-Bakr MH, Anderer P et al. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26(2):249-260.
24. Nierenberg AA, Adler LA, Peselow E, et al. Trazodone for antidepressant-associated insomnia. Am J Psychiatry. 1994;151(7): 1069-1072.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association Press; 1994.
26. Rechtschaffen A, Kales A, eds. A Manual of Standardized Terminology Techniques and Scoring System for Sleep States of Human Subjects. Washington, DC: US Government Printing Office; 1968.
27. Bonnet M, Carley D, Carskadon M, et al. (Atlas Task Force). EEG arousals: scoring rules and examples. Sleep. 1992;15:173-184.
28. Rechtschaffen A, Verdone P. Amount of dreaming: effect of incentive, adaptation to laboratory, and individual differences. Percept Mot Skills. 1964;19:947-958.
29. Le Bon O, Staner L, Hoffmann G, et al. The first-night effect may last more than one night. J Psychiatr Res. 2001;35:165-172.
30. Mouret J, Lemoine P, Minuit MP, et al. Effects of trazodone on the sleep of depressed subjects - a polygraphic study. Psychopharmacology. 1988;95:537.
31. Scharf MB, Sachais BA. Sleep laboratory evaluation of the effects and efficacy of trazodone in depressed insomniac patients. J Clin Psychiatry. 1990;51(9):13-17.
32. Walsh JK, Erman M, Jamieson A, et al. Subjective hypnotic efficacy of trazodone and zolpidem in DSM-III-R primary insomnia. Human Psychopharm. 1998;13:191-198.
33. Parrino L, Spaggiari MC, Boselli M, et al. Clinical and polysomnographic effects of trazodone CR in chronic insomnia associated with dysthymia. Psychopharmacology. 1994;116(4):389-395.
34. Yamadera H, Suzuki H, Nakamura S, et al. Effects of trazodone on polysomnography, blood concentration and core body temperature in healthy volunteers. Psychiatry Clin Neurosci. 1999;53(2):189-191.
35. Yamadera H, Nakamura S, Suzuki H, et al. Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects. Psychiatry Clin Neurosci. 1998;52(4):439-443.
36. Gillin JC, Smith TL, Irwin M, et al. Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry. 1994;51(3):189-197.
37. Clark CP, Gillin JC, Golshan S, et al. Polysomnography and depressive symptoms in primary alcoholics with and without a lifetime diagnosis of secondary depression and in patients with primary major depression. J Affect Disord. 1999;52(1-3):177-185.
38. Gann H, Feige B, Hohagen F, et al. Sleep and the cholinergic rapid eye movement sleep induction test in patients with primary alcohol dependence. Biol Psychiatry. 2001;50(5):383-390.
39. Crome P, Ali C. Clinical features and management of self-poisoning with newer antidepressants. Med Toxicol. 1986;1(6):411-20.
40. de Jonghe F, Swinkels JA. The safety of antidepressants. Drugs. 1992;43(suppl 2):40-46; discussion 46-47.
41. Ayd FJ Jr, Settle EC Jr. Trazodone: a novel, broad-spectrum antidepressant. Mod Probl Pharmacopsychiatry. 1982;18:49-69.
42. Hayes PE, Kristoff CA. Adverse reactions to five new antidepressants. Clin Pharm. 1986;5(6):471-480.
43. Gamble DE, Peterson LG. Trazodone overdose: four years of experience from voluntary reports. J Clin Psychiatry. 1986;47(11):544-546.